Introduction
Cardiorenal syndrome is characterized by concomitant kidney disease and diastolic heart failure. 1 -3 In patients with type 2 diabetes mellitus, renal insufficiency commonly progresses as part of cardiorenal syndrome, 4 but clinical trials focusing on this syndrome in patients with diabetes mellitus have been limited by the heterogeneity of patient populations and nonstandardized endpoints. 3, 5 A previous study undertaken by our research group focused on early stage cardiorenal disease in patients with type 2 diabetes who had a mild-to-moderate decrease in estimated glomerular filtration rate (eGFR) and incipient left ventricular (LV) relaxation impairment. 6 That study, which involved patients with no history of cardiovascular disease and normal LV systolic function, demonstrated an inverse correlation between eGFR and peak velocity of early transmitral flow/peak velocity of early diastolic mitral annular motion ratio M Pecková, J Charvat, O Schuck et al. Plasma adrenomedullin and subclinical cardiorenal syndrome (E/E′), which is a noninvasive echocardiography parameter of LV end-diastolic pressure; E′ is a measure of LV relaxation. 6 Cardiovascular and renal homeostasis are influenced by many peptides including natriuretic hormones, plasma levels of which have been shown to correlate positively with GFR 7, 8 and LV end-diastolic pressure (E/E′). 9 -11 Adrenomedullin, a vasoactive peptide originally isolated from pheochromocytoma, 12,13 is expressed in cardiovascular tissue such as the cardiac atria and ventricles. 14 Adrenomedullin increases GFR in patients with renal function impairment and prevents cardiac failure via its vasodilatory effect. 13, 15 In our opinion, adrenomedullin may play an important role in cardiorenal interactions in the early stages of heart and kidney dysfunction in patients with type 2 diabetes mellitus. The aim of the current analysis of data from our earlier study 6 was to evaluate whether plasma adrenomedullin is involved in the association between E/E′ and eGFR in patients with type 2 diabetes mellitus and subclinical cardiorenal syndrome (mild-tomoderate impairment of renal function and LV relaxation impairment). 
Patients and methods

PATIENT POPULATION
STATISTICAL ANALYSES
Normally distributed continuous variables were presented as mean ± SD. Between-group comparisons were performed using unpaired Student's t-test for continuous variables and χ 2 -test for categorical variables. Relationships between continuous variables were assessed with bivariate and multivariate regression analyses, using the method of orthogonal projections to latent structure. 24 A P-value < 0.05 was considered to be statistically significant. The value (R c ) 2 expressed the percentage variation of the matrix of the dependent variable that was explained by the independent variables. The effect of plasma adrenomedullin concentration on the relationship between E/E′ and eGFR was examined by multivariate linear regression analysis, with plasma adrenomedullin concentration as a constant (correlation coefficient = 0; P = 1.00). Data were analysed using Statgraphics ® Centurion Data Analysis and Statistical Software, version XV (Statpoint Technologies, Warrenton, VA, USA).
Results
The study included 82 patients with type 2 diabetes mellitus, of whom 38 were diagnosed with LV relaxation impairment (E′ ≤ 7.1 cm/s); 44 were without LV relaxation impairment (E′ > 7.1 cm/s). Demographic, clinical and echocardiographic data for the two patient groups are shown in Table 1 . Plasma adrenomedullin concentrations were significantly lower in patients being treated for arterial hypertension than in normotensive patients (1.96 ng/ml versus 3.06 ng/ml, respectively; P = 0.001).
Bivariate linear regression analysis revealed a significant positive correlation between eGFR and plasma adrenomedullin concentration in both patient subgroups (E′ ≤ 7.1 cm/s, R 2 = 0.187, P < 0.0066; E′ > 7.1 cm/s, R 2 = 0.116, P < 0.0236; Fig. 1 ). There was a significant inverse correlation between E/E′ and plasma adrenomedullin concentration in patients with LV relaxation impairment (E′ ≤ 7.1 cm/s; R 2 = 0.154, P = 0.014; Fig. 2A ), but not in patients with E′ > 7.1 cm/s (Fig. 2B) . Multivariate analyses revealed that male gender, treatment for arterial hypertension, plasma adrenomedullin concentration, and age, BMI, E/E′ and triglyceride levels were independent predictors of eGFR (Table 2 ). In addition, E/E′, HbA 1c and the duration of diabetes mellitus were independent predictors of E′. The independent predictors of E/E′ were treatment for arterial hypertension and eGFR, plasma adrenomedullin concentration and E′.
Our previous study demonstrated a significant correlation between E/E′ and eGFR in patients with LV relaxation impairment (E′ ≤ 7.1 cm/s; R 2 = 0.14, P = 0.021). 6 Multivariate linear regression analysis in the present study found no significant correlation between E/E′ and eGFR when plasma adrenomedullin concentration was assumed to be constant. 
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Discussion
In our previous study in this population of patients with type 2 diabetes, well-controlled blood pressure and no history of cardiovascular disease, impaired LV relaxation (E′ ≤ 7.1 cm/s) was the underlying condition in the association between a mild-to-moderate decrease in eGFR and the noninvasive parameter of LV end-diastolic pressure (E/E′). 6 All of the patients with type 2 diabetes mellitus included in this current analysis had some degree of renal function impairment, but normal or borderline E/E′ ratios.
Subclinical cardiac abnormalities in patients with type 2 diabetes mellitus and no history of overt heart disease begin to appear when LV relaxation impairment reaches a critical point. 25 We have previously demonstrated a significant inverse correlation between E/E′ and eGFR in patients with E′ ≤ 7.1 cm/s, 6 which is the accepted cut-off value for impaired LV and heart abnormalities were present in patients with type 2 diabetes and LV relaxation impairment. The inverse correlation between E/E′ and eGFR observed in patients with LV relaxation impairment cannot be explained by the effect of natriuretic hormones. 8 This current analysis focused on the role of adrenomedullin, which significantly improves GFR in patients with renal insufficiency, and causes vasodilation and reduced blood pressure. 13, 15, 26 Plasma adrenomedullin concentration and eGFR were positively correlated in patients with and without LV relaxation impairment in the present study. There was also a significant inverse correlation between plasma adrenomedullin concentration and E/E′ in patients with impaired LV relaxation. This finding was supported by multivariate linear regression analysis, where the significant inverse correlation between E/E′ and eGFR in patients with E′ ≤ 7.1 cm/s was abolished when the plasma adrenomedullin concentration was considered to be constant, indicating that adrenomedullin acts as an independent factor in the relationship between E/E′ and eGFR.
Plasma adrenomedullin concentrations were significantly lower in patients treated for arterial hypertension compared with normotensive patients in the present study. There were no significant between-group differences in the number of patients receiving each main type of antihypertensive agent (β-blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and diuretics), suggesting that the use of antihypertensive agents cannot explain these findings. 2 is the equivalent of the β-coefficient (expresses the percentage variation of the matrix of the dependent variable explained by the independent variables). BMI, body mass index; HbA 1c , glycosylated haemoglobin.
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• Revised accepted 14 June 2012 Copyright © 2012 Field House Publishing LLP Plasma adrenomedullin concentrations are low in healthy subjects but increase with progressive cardiac and renal failure, with higher concentrations being associated with poorer prognosis. 27 -31 Higher plasma adrenomedullin concentrations were associated with lower LV end-diastolic pressure (E/E′) in patients with impaired LV relaxation in the current study. Elevated filling pressure (LV end-diastolic pressure > 16 mmHg) is the main physiological consequence of diastolic dysfunction, 32, 33 and a higher mitral E/E′ ratio has been associated with increased morbidity and adverse outcome. 32, 34 The beneficial effect of adrenomedullin on haemodynamics in the early stage of heart and kidney disease was supported by the significant positive correlation between plasma adrenomedullin concentration and eGFR, as observed in the present study. Although this relationship was not dependent on cardiac function, the association between plasma adrenomedullin concentration and E/E′ in patients with LV relaxation impairment suggests that adrenomedullin is involved in modulating the cardiorenal connection. Adrenomedullin may prevent the development of diastolic heart failure and the progression of renal dysfunction at this stage of cardiorenal syndrome. 35, 36 In conclusion, the findings reported in this analysis support the hypothesis that adrenomedullin modulates the interaction between the heart and kidneys in the early subclinical stages of cardiorenal syndrome in patients with type 2 diabetes mellitus.
